These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 9735235)
1. Apoptosis in esophageal cancer following induction chemoradiotherapy. Shears LL; Ribeiro U; Kane J; Safatle-Ribeiro A; Watkins S; Posner M J Surg Res; 1998 Sep; 79(1):20-4. PubMed ID: 9735235 [TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
3. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
4. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Posner MC; Gooding WE; Lew JI; Rosenstein MM; Lembersky BC Surgery; 2001 Oct; 130(4):620-6; discussion 626-8. PubMed ID: 11602892 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203 [TBL] [Abstract][Full Text] [Related]
7. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial]. Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661 [TBL] [Abstract][Full Text] [Related]
8. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report. Henry LR; Goldberg M; Scott W; Konski A; Meropol NJ; Freedman G; Weiner LM; Watts P; Beard M; McLaughlin S; Cheng JD Ann Surg Oncol; 2006 Feb; 13(2):214-20. PubMed ID: 16418887 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma. Yang B; Rice TW; Adelstein DJ; Rybicki LA; Goldblum JR Mod Pathol; 1999 Mar; 12(3):251-6. PubMed ID: 10102609 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer. Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy. Gibson MK; Abraham SC; Wu TT; Burtness B; Heitmiller RF; Heath E; Forastiere A Clin Cancer Res; 2003 Dec; 9(17):6461-8. PubMed ID: 14695149 [TBL] [Abstract][Full Text] [Related]
14. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160 [TBL] [Abstract][Full Text] [Related]
15. [Long term results of esophageal epidermoid cancers in complete remission after preoperative chemo-radiotherapy]. Triboulet JP; Amrouni H; Guillem P; Vandenhaute B; Lecomte-Houcke M; Adenis A Ann Chir; 1998; 52(6):503-8. PubMed ID: 9752498 [TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease. El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037 [TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma. Samejima R; Kitajima Y; Yunotani S; Miyazaki K Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609 [TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862 [TBL] [Abstract][Full Text] [Related]
19. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. Kang SY; Han JH; Lee KJ; Choi JH; Park JI; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Oh YT; Chun M; Kim JH; Sheen SS; Lim HY Clin Cancer Res; 2007 Jul; 13(14):4146-53. PubMed ID: 17634542 [TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report. Fujiwara Y; Kamikonya N; Inoue T; Koishi K; Yoshikawa R; Nakao K; Yagyu R; Nishiwaki M; Fujiwara M; Kojima S; Nakagawa K; Yamamura T Oncol Rep; 2005 Nov; 14(5):1177-82. PubMed ID: 16211282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]